Insights
Featured Carousel
- COVID-19: Economic Relief Programs
- An Alternative Paradigm to ‘On the Purpose of the Corporation’
- Russia Seeks to Protect Sanctioned Entities From Claims in Foreign Courts or Foreign Arbitral Institutions
- Guidance on Carbon Capture and Sequestration Tax Credit Provides Clarity for Developers and Investors
Topics Panel Section
With its June 10, 2020, decision in Nguyen v. Endologix, Inc., the Ninth Circuit has potentially given securities defendants — particularly those in the pharmaceutical, biotech and medical device space — a powerful tool to resist meritless claims, especially where the plaintiff fails to plead any motive to commit fraud.
Ninth Circuit Holds That Courts Should Scrutinize Economic Plausibility of Securities Fraud Complaints in Evaluating Scienter
The FDA has offered a temporary solution to the challenge of distributing drug samples during COVID-19. The new guidance, which allows drug samples to be shipped directly to patients’ homes and permits alternative forms of receipt and verification, is welcome news for manufacturers and authorized distributors.
FDA Issues Guidance on Prescription Drug Sample Distribution During COVID-19
In this month's edition of our Privacy & Cybersecurity Update, we examine the National Institute of Standards and Technology's four principles of the "explainability" of artificial intelligence and the U.K. Information Commissioner's Office's guidance on artificial intelligence. We also look at the final regulations of the California Consumer Privacy Act, guidance released by a group of U.S. federal agencies regarding anti-drone technologies and the FTC's continued enforcement of the EU-U.S. Privacy Shield.
Privacy & Cybersecurity Update
Expansions to the Antiterrorism Act of 1990, invoked in recent cases, create secondary liability for any entity or person that knowingly “aids or abets” a terrorist act, and narrow the defenses available in such actions. These amendments may create exposure for seemingly ordinary course business activities around the world, and the reputational impact may be significant for defendants in ATA cases and those who conduct business with them.
The Potential Impact of Terrorism Lawsuits Under the Antiterrorism Act on Ordinary Corporate, Banking and Sovereign Enterprises
Latest From Skadden
-
New DOJ Merger Remedies Manual: Preference for Structural Remedies and Private Equity BuyersSeptember 21, 2020
-
A Brief Response Regarding Stakeholder GovernanceSeptember 18, 2020
-
Anthem/Cigna Litigation Underscores Importance of Antitrust Planning in TransactionsSeptember 16, 2020
Upcoming Speaking Engagements
-
17th Annual Executive Compensation ConferenceSeptember 23, 2020
-
SIFMA C&L Virtual ForumSeptember 23-24, 2020
-
Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2020October 14-16, November 11-13, December 2-4, 2020
-
The Law and Business of Open Source Software 2020November 2, 2020